RiTUXimab

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36698 publications

Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies.

Prevalence of anti-rituximab antibodies in autoimmune forms of glomerulonephritis and podocytopathies.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 24, 2026

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with a primary focus on rituximab and belimumab.

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with a primary focus on rituximab and belimumab.

Journal: Expert opinion on biological therapy
Published: June 23, 2026

IgG4-related disease presenting as an omental mass.

IgG4-related disease presenting as an omental mass.

Journal: BMJ case reports
Published: June 23, 2026

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Journal: Expert opinion on biological therapy
Published: June 23, 2026

The successful use of rituximab in children with IgA nephropathy and minimal change-like lesions: a case series.

The successful use of rituximab in children with IgA nephropathy and minimal change-like lesions: a case series.

Journal: Renal failure
Published: June 23, 2026

Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency.

Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency.

Journal: NEJM evidence
Published: June 23, 2026

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID -Dexamethasone versus Rituximab in PGNMID.

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID -Dexamethasone versus Rituximab in PGNMID.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 23, 2026

An update on the pharmacological management of ANCA vasculitis.

An update on the pharmacological management of ANCA vasculitis.

Journal: Expert review of clinical immunology
Published: June 20, 2026

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

Journal: Future oncology (London, England)
Published: June 19, 2026

Efficacy and safety of rituximab in children with refractory nephrotic syndrome

Efficacy and safety of rituximab in children with refractory nephrotic syndrome

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: June 17, 2026

Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review.

Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review.

Journal: Lupus
Published: June 16, 2026

Warm Autoimmune Hemolytic Anemia Presenting 21 Years After Liver Transplantation: A Case Report.

Warm Autoimmune Hemolytic Anemia Presenting 21 Years After Liver Transplantation: A Case Report.

Journal: The American journal of case reports
Published: June 16, 2026
Showing 1-12 of 36,698

Last Updated: 06/30/2026